AstraZeneca and Oxford University’s potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas.

Region:

World

Category:

Society

Author/s:

By EFE, The Lancet, Reuters